News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Akorn, Inc. (AKN)’s Chairman Adopts 10b5-1 Trading Plan



9/24/2012 10:11:01 AM

LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX), a niche specialty pharmaceutical company, today announced that its Chairman, Dr. John N. Kapoor, on his own behalf and on behalf of several trusts of which he is a trustee, have each established pre-arranged trading plans to sell a portion of their shares in the Company over a designated period for estate planning purposes. The plans were adopted in accordance with Rule 10b5-1 of the Securities and Exchange Act of 1934.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES